BlackRock Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History

BlackRock Investment Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.94M	Buy	373,148 +65,671	+21%	+$1.12M	0.01%	1602
2016 Q3	$7.29M	Buy	307,477 +3,686	+1%	+$99.1K	0.01%	1227
2016 Q2	$8.76M	Buy	303,791 +25,698	+9%	+$838K	0.01%	1044
2016 Q1	$8.9M	Buy	278,093 +7,770	+3%	+$273K	0.01%	997
2015 Q4	$11.6M	Buy	270,323 +1,313	+0.5%	+$52.5K	0.01%	854
2015 Q3	$9.47M	Sell	269,010 -4,145	-2%	-$187K	0.01%	960
2015 Q2	$12.5M	Buy	273,155 +20,954	+8%	+$995K	0.02%	858
2015 Q1	$11.8M	Buy	252,201 +2,716	+1%	+$108K	0.02%	846
2014 Q4	$7.9M	Sell	249,485 -1,939	-0.8%	-$56.7K	0.01%	1087
2014 Q3	$5.96M	Buy	251,424 +2,053	+0.8%	+$52.6K	0.01%	1222
2014 Q2	$7.48M	Sell	249,371 -19,820	-7%	-$535K	0.01%	1145
2014 Q1	$7.11M	Buy	269,191 +2,957	+1%	+$73.9K	0.01%	1126
2013 Q4	$6.69M	Sell	266,234 -5,329	-2%	-$119K	0.01%	1154
2013 Q3	$5.56M	Buy	271,563 +1,682	+0.6%	+$34.7K	0.01%	1212
2013 Q2	$5.38M	Buy	+269,881	New	+$4.79M	0.01%	1166

Other funds holding IPXL

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Investment Management's IPXL Position: Q4 2016 in Review

BlackRock Investment Management increased its Impax Laboratories, Inc. (IPXL) stake by 21% in Q4 2016, buying an estimated $1.12M and bringing the position to 373,148 shares worth $4.94M. The position accounts for 0.01% of the portfolio, ranked #1602.

BlackRock Investment Management first reported a position in IPXL in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.5M in Q2 2015. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

BlackRock Investment Management held 373,148 shares of Impax Laboratories, Inc. worth $4.94M as of Q4 2016.
BlackRock Investment Management bought 65,671 Impax Laboratories, Inc. shares in Q4 2016, an estimated $1.12M.
Impax Laboratories, Inc. made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1602 holding.
BlackRock Investment Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Impax Laboratories, Inc. position peaked at $12.5M in Q2 2015.
198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.